NCBI . NLM . NIH . GOV {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Ncbi.nlm.nih.gov Make Money
Keywords
Topics
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC4390506/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC4390506/. The analysis below is for the second page.

Title[redir]:
Induction of T-cell immunity overcomes complete resistance to PD-1 and CTLA-4 blockade and improves survival in pancreatic carcinoma - PMC
Description:
Disabling the function of immune checkpoint molecules can unlock T-cell immunity against cancer, yet despite remarkable clinical success with monoclonal antibodies (mAb) that block PD-1 or CTLA-4, resistance remains common and essentially ...

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 6,399,052 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We can't figure out the monetization strategy.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Ncbi.nlm.nih.gov might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

doi, tumor, mice, cells, pda, pubmed, google, scholar, cancer, tumors, pdl, pmc, article, free, pancreatic, expression, tcell, fig, kpc, survival, model, subcutaneous, cell, immune, treated, blockade, checkpoint, treatment, αpd, αcdchemotherapy, antitumor, immunity, ctla, response, human, observed, res, αcd, supplementary, clinical, ifnγ, αctla, day, microenvironment, patients, data, growth, med, antibodies, melanoma,

Topics {✒️}

survived tumor-free long-term tumor-free wild-type mice long-term tumor-free survival cd40/gemcitabine/nab-paclitaxel converts pda macrophage-independent t-cell response αcd40/gemcitabine/nab-paclitaxel potentiates efficacy results pd-1/pd-l1 axis long-term complete remission t-cell stimulatory therapies enhance t-cell immunity anti-pd-l1 antibody mpdl3280a antitumor t-cell responses induced t-cell immunity control-treated tumor-bearing mice pmc beta search unlock t-cell immunity rendering long-term survival cd8+ t-cell infiltrate pancreas-specific promoter pdx-1 fc receptor-null mice subcutaneous tumor-bearing mice paraffin-embedded tissue samples cd8+ t-cell infiltration t-cell selective pressure t-cell effector phase t-cell depletion studies t-cell checkpoint immunotherapy tumor-bearing kpc mice tumor pd-l1 score b7-h1 expression clinical grade nab-paclitaxel drive pd-l1 expression pd-l1 expression score mirroring pd-l1 expression affect pd-l1 expression intratumoral t-cell populations pd-1/pd-l1 axis cell-dependent antitumor regression cd8+ t-cell depletion pd-1 receptor-deficient mice minimal pd-l1 expression cell-dependent tumor regression immune-based antitumor effects anti-pd-l1 antibody gm-csf gene survived long-term αcd40/chemotherapy converts pda therapeutic t-cell induction tumor pd-l1 expression pd-l1 tumor expression

Social Networks {👍}(6)

External Links {🔗}(171)

Analytics and Tracking {📊}

Google Analytics
Google Analytics 4
Google Tag Manager

Libraries {📚}

jQuery
jQuery module (jquery-3.6.0)
Zoom.js

Emails and Hosting {✉️}

Mail Servers:

nihcesxway.hub.nih.gov
nihcesxway2.hub.nih.gov
nihcesxway3.hub.nih.gov
nihcesxway4.hub.nih.gov
nihcesxway5.hub.nih.gov

Name Servers:

dns1-ncbi.ncbi.nlm.nih.gov
dns2-ncbi.ncbi.nlm.nih.gov
lhcns1.nlm.nih.gov
lhcns2.nlm.nih.gov

CDN Services {📦}

Ncbi

3.89s.